Alembic Pharmaceuticals informs about press release

21 Mar 2022 Evaluate
Alembic Pharmaceuticals has informed that it has enclosed press release titled, ‘Alembic Pharmaceuticals receives USFDA Final Approval for Lacosamide Tablets USP, 50 mg, 100 mg, 150 mg, and 200 m’.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

761.30 -9.55 (-1.24%)
24-Feb-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1734.00
Dr. Reddys Lab 1308.50
Cipla 1330.50
Zydus Lifesciences 906.20
Lupin 2248.95
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×